PamGene
's-hertogenbosch
About PamGene
PamGene has a unique proprietary array-based platform to measure the activities of kinases & nuclear receptors, enabling deeper understanding of drug interactions with these important classes of signalling molecules. PamGene's patented technology finds a wide range of applications including lead identification and optimization, (pre) clinical translational research and biomarker development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.3M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2023)
- Website: pamgene.com
- Phone: +310736158080
Industries & Categories
Biotechnology, Clinical Trials, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/pamgene-107965 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.